Sanofi | SAN
Stock Price
93.17
Daily Change
2.30 2.53%
Monthly
-5.52%
Yearly
8.04%
Q4 Forecast
96.25


Peers Price Chg Day Year Date
AbbVie 177.16 5.32 3.10% 27.76% Nov/22
Aena 200.40 0.80 0.40% 28.54% Nov/22
Alcon AG 76.68 0.78 1.03% 18.37% Nov/22
Almirall 8.47 0.18 2.11% 0.89% Nov/22
Amgen 294.64 4.72 1.63% 10.99% Nov/22
Amarin 0.55 0.02 4.52% -29.92% Nov/22
AstraZeneca 10,474.00 412.00 4.09% 2.95% Nov/22
Bayer 19.80 0.28 1.46% -39.90% Nov/22
Biogen 157.88 -0.16 -0.10% -31.93% Nov/22
BMW 67.80 -0.14 -0.21% -27.97% Nov/22
Bristol-Myers Squibb 58.86 0.66 1.13% 18.29% Nov/22
Mercedes-Benz AG 52.27 0.42 0.81% -10.25% Nov/22
Vinci 100.70 0.05 0.05% -8.44% Nov/22
Essilor 235.30 2.90 1.25% 32.38% Nov/22
Fresenius Medical Care 42.25 0.81 1.95% 16.49% Nov/22
Fresenius 33.31 0.52 1.59% 19.22% Nov/22
Genmab 1,483.50 36.00 2.49% -30.68% Nov/22
Gilead Sciences 90.01 0.40 0.45% 19.41% Nov/22
Galapagos 25.38 1.42 5.93% -25.57% Nov/22
GRIFOLS 10.60 0.20 1.92% -17.61% Nov/22
GlaxoSmithKline 1,342.00 32.50 2.48% -5.56% Nov/22
Hikma Pharmaceutical 1,950.00 78.00 4.17% 11.24% Nov/22
J&J 155.20 -0.32 -0.21% 1.77% Nov/22
Eli Lilly 747.50 -0.71 -0.09% 24.36% Nov/22
Lonza 521.40 -0.20 -0.04% 48.25% Nov/22
Merck 141.75 3.45 2.49% -11.93% Nov/22
Merck 99.27 -0.86 -0.86% -2.55% Nov/22
Novartis 93.68 2.12 2.32% 8.61% Nov/22
Orion 45.23 0.84 1.89% 21.91% Nov/22
Pfizer 25.66 0.56 2.23% -15.87% Nov/22
Philips 25.22 0.19 0.76% 28.83% Nov/22
Recordati 52.10 1.45 2.86% 16.95% Nov/22
Regeneron Pharmaceuticals 738.00 -5.43 -0.73% -7.55% Nov/22
Roche Holding 254.30 3.20 1.27% 6.69% Nov/22
Sanofi 93.17 2.30 2.53% 8.04% Nov/22
SAP 225.90 1.20 0.53% 58.53% Nov/22
UCB 180.00 5.85 3.36% 160.12% Nov/22
Volkswagen 81.80 0.56 0.69% -23.25% Nov/22

Indexes Price Day Year Date
EU50 4790 34.12 0.72% 9.83% Nov/22
FR40 7255 41.69 0.58% -0.31% Nov/22
EU100 1444 8.94 0.62% 6.71% Nov/22
EU600 508 5.93 1.18% 10.91% Nov/22

Sanofi traded at 93.17 this Friday November 22nd, increasing 2.30 or 2.53 percent since the previous trading session. Looking back, over the last four weeks, Sanofi gained 5.52 percent. Over the last 12 months, its price rose by 8.04 percent. Looking ahead, we forecast Sanofi to be priced at 96.25 by the end of this quarter and at 92.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.